| For: | Sato-Espinoza K, Valdivia-Herrera M, Chotiprasidhi P, Diaz-Ferrer J. Hepatocellular carcinoma in patients without cirrhosis. World J Gastroenterol 2025; 31(23): 107100 [PMID: 40575339 DOI: 10.3748/wjg.v31.i23.107100] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v31/i23/107100.htm |
| Number | Citing Articles |
| 1 |
Nan Ye, Yunxiao Lv, Bin Wang, Sicong Zhao, Jing Zhao. Analysis of Risk Factors and Construction of Risk Prediction Model for Patients With First Recurrence After Initial Curative Resection for Hepatocellular Carcinoma. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2026; 36(4) doi: 10.1097/SLE.0000000000001466
|
| 2 |
Niall P. Hardy, Jonas Santol, Yawen Dong, David Pereyra, Vanja Podrascanin, Omar Haque, Jessica Heard, Matthias Ilmer, Zhihao Li, Beat Moeckli, Jule Dingfelder, Soeren Holst, Florian Lehner, Laura Helmreich, Iwan Wukits, Jennifer L. Leiting, Susanne G. Warner, Rory L. Smoot, Michael L. Kendrick, Mark J. Truty, Julie K. Heimbach, Georg Gyoeri, Thomas Gruenberger, Timucin Taner, Patrick P. Starlinger. Liver parenchymal quality stratifies outcomes after hepatic resection for hepatocellular carcinoma. Liver Transplantation 2026; doi: 10.1097/LVT.0000000000000963
|
| 3 |
Alexis Gumm, Elizabeth B. Rand, Alyssa Kriegermeier. Fontan-Associated Liver Disease. Clinics in Liver Disease 2026; doi: 10.1016/j.cld.2026.07.006
|
| 4 |
Rui Wang. Metabolic dysfunction-associated fatty liver disease: redefining the conceptual framework from nomenclature to emerging therapeutic paradigms. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1950107
|
| 5 |
Shahid A. Khan, Mathew Vithayathil, Terry C.F. Yip, Hashem B. El-Serag. The changing epidemiology of primary liver cancer in the 21st century. Journal of Hepatology 2026; 85(4) doi: 10.1016/j.jhep.2026.01.018
|
| 6 |
Yu.M. Stepanov, N.Yu. Zavhorodnia, O.M. Vlasova. Hepatocellular carcinoma: modern aspects of interdisciplinary management. Part 1. Epidemiology, risk factors, diagnosis. GASTROENTEROLOGY 2025; 59(3) doi: 10.22141/2308-2097.59.3.2025.694
|
| 7 |
Aparna Morgan, Angela Zhu, Nicholas Hannah, James Haridy, Ashok Raj, Neeraj Bhala. Letter to the Editor: Hepatocellular carcinoma in patients without cirrhosis - urgent need to include Australasian populations. World Journal of Gastroenterology 2026; 32(28): 117785 doi: 10.3748/wjg.117785
Abstract(83) |
Core Tip(61) |
Full Article(HTML)(305)
|
Full Article (PDF)-1272K(33)
|
Full Article with Cover (PDF)-1574K(27)
|
Full Article (XML)-44K(21)
|
Audio-755K(3)
|
Peer-Review Report-240K(27)
|
Answering Reviewers-228K(31)
|
Supplementary Material-147K(29)
|
Times Cited (0)
|
Total Visits (468)
|
Open
|
| 8 |
Zilong Zhang, Xiaoping Chen, Bixiang Zhang, Wanguang Zhang, Ze-yang Ding. Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2026; 1881(1) doi: 10.1016/j.bbcan.2025.189517
|
| 9 |
Cher Heng Tan, Hanyu Jiang, Yuan-Cheng Wang, Hsien Min Low, Christopher Welle, Shuwei Zhou, Giuseppe Brancatelli, Sudhakar Venkatesh, Jeong Min Lee. MRI of Hepatocellular Carcinoma: Cross-regional Perspectives on Trends and Opportunities. RadioGraphics 2026; 46(9) doi: 10.1148/rg.260001
|
| 10 |
Dan Wang, Keyi Jiang, Hongqi Feng, Liwei Zhang, Dandan Li, Songbo Fu, Yue Sun. Lapatinib Promotes Apoptosis in Hepatoma Cells by Regulating SPP1 Expression. Anti-Cancer Agents in Medicinal Chemistry 2026; 26(14) doi: 10.2174/0118715206403825251031165626
|
| 11 |
Lorenz Balcar, Leonardo Brunetti, Katharina Pomej, Abelina Kreuter, Claudia Angela Maria Fulgenzi, Ahmer Adnan, Tobias Meischl, Antonio D’Alessio, Giulia Manfredi, Hong Jae Chon, Naoshi Nishida, Pei-Chang Lee, Celina Ang, Anja Krall, Najib Ben Khaled, Bernardo Stefanini, Tiziana Pressiani, Joe Ramzi Eid, Anwar Saeed, Alessandro Parisi, Yi-Hsiang Huang, Ashwini Arvind, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Natascha Röhlen, Arndt Vogel, Kornelius Schulze, Johann von Felden, Marianna Silletta, Michael Trauner, Ilario Giovanni Rapposelli, Henning Wege, Fabio Piscaglia, Peter R. Galle, Rudolf Stauber, Masatoshi Kudo, Amit G. Singal, Susanna V. Ulahannan, Haripriya Andanamala, Andrea Casadei-Gardini, Iakow Bolnykh, Sarah Mouri, Charles Roux, Ahmed Kaseb, Lorenza Rimassa, Beodeul Kang, Ciro Celsa, Michael Li, Mario Pirisi, Calogero Cammà, Giuseppe Cabibbo, Eleonora Alimenti, Massimo Iavarone, Pasquale Lombardi, Robin Kate Kelley, Marta Fortuny, Maria Reig, Andrea Dalbeni, Hidenori Toyoda, Wei-Fan Hsu, Chun-Yen Lin, Po Ting Lin, Bernhard Scheiner, Manon Allaire, David J. Pinato, Matthias Pinter. Prognostic role of the Child-Turcotte-Pugh classification and ALBI grade in patients without cirrhosis and hepatocellular carcinoma. JHEP Reports 2026; doi: 10.1016/j.jhepr.2026.102053
|
| 12 |
Su Yin Lau, Victoria Sinq‐Ling Kok, Soek‐Siam Tan, Syuhada Dan Adnan, Wei‐Lin Ng, Ban‐Hong Ang, Nur Yazmin Yaacob, Yeong Yeh Lee, Senamjit Kaur, Rosmawati Mohamed, Ping‐Foo Wong, Lee‐Ling Lim, Mohana Letchumanan, Shireene Ratna Vethakkan, Nurain Mohd Noor, Siow‐Foon Tan, Tiong‐Lim Low, Lee‐Boon Kiew, Wah‐Kheong Chan. The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia. Journal of Gastroenterology and Hepatology 2026; 41(9) doi: 10.1111/jgh.70643
|
| 13 |
Jiayi Li, Shixi Zhang. KIFC1 as a prognostic biomarker for hepatocellular carcinoma. Asian Journal of Surgery 2026; doi: 10.1016/j.asjsur.2026.08.049
|
| 14 |
Tomohide Hori. Impact of alcohol-associated and metabolic dysfunction-associated steatotic liver diseases upon hepatic disorder and carcinogenesis in the current era. World Journal of Hepatology 2025; 17(11): 112359 doi: 10.4254/wjh.v17.i11.112359
|
| 15 |
Yulong Deng, Beibei Huang, Yuxing Tang, Qinyan Su, Hongquan Liu, Hongbo Mo, Huanhuan Tang, Kunhua Xiong, Shipei He, Yiwu Dang, Gang Chen, Minhua Rong. Multimodal Analysis Reveals Aberrant Expression of SUMO2 and Its Significant Association With Key Mechanisms of Metabolic Pathways in Hepatocellular Carcinoma. Frontiers in Bioscience-Landmark 2026; 31(8) doi: 10.31083/FBL52385
|
| 16 |
Abir Oufrid, Basma Aabboub, Diango Keita, Sara Nejjari, Samia El Hakym, Hafssa El Hilali, Chaymae Chbihi, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Nawfel Mellas. Metastatic Hepatocellular Carcinoma in a Non-Cirrhotic Liver without Viral Hepatitis: A Case Report and Literature Review. Journal of Cancer Therapy 2026; 17(01) doi: 10.4236/jct.2026.171007
|
| 17 |
Taotao Yan, Ming-Lun Yeh, Jennifer Leong, Hidenori Toyoda, Hiroshi Abe, Dae Won Jun, Lewis Roberts, Yasuhito Tanaka, Myron Schwartz, Yao-Chun Hsu, Charles Landis, Phillip Vutien, Haruki Uojima, Takashi Honda, Maria Buti, Huy Trinh, Eiichi Ogawa, Satoshi Yasuda, Cheng-Hao Tseng, Mayumi Maeda, Elsa Sola, Takanori Suzuki, Chung-Feng Huang, Pei-Chien Tsai, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ramsey Cheung, Ming-Lung Yu, Mindie H. Nguyen. Sex Differences in Mortality Among Patients With Hepatocellular Carcinoma. JAMA Network Open 2026; 9(10) doi: 10.1001/jamanetworkopen.2026.37313
|
| 18 |
Ruijuan Wang, Chang Liu, Mei Xue, Jun Qian, Yue Hu. Artificial intelligence for metabolic dysfunction-associated steatotic liver disease diagnosis: A systematic review. Computers in Biology and Medicine 2026; 208 doi: 10.1016/j.compbiomed.2026.111619
|
| 19 |
Mariana M. Ramírez-Mejía, Mariana Montoya-López, Saraí Gómez-Camacho, Fernanda M. Martínez-Díaz, Elsie A. Jiménez-Cuevas, Nahum Méndez-Sánchez. Metabolic Dysfunction-Associated Steatotic Liver Disease [Working Title]. 2026; doi: 10.5772/intechopen.1017917
|
| 20 |
Xinyi Cao, Zhao Cao, Huan Zeng, Yao Hu, Cuiping Zhang, Guoquan Yan, Lei Zhang, Hong Shu, Haojie Lu, Ming Guan. Site-specific glycosylation of serum antithrombin-III as a potential biomarker for AFP-negative HCC. Clinica Chimica Acta 2027; 594 doi: 10.1016/j.cca.2026.121331
|